Status:
COMPLETED
Hemodynamic Monitoring in Liver Transplant With VEnaRt Cardiac Output Versus Swan-Ganz Catheter (VERO Study)
Lead Sponsor:
Azienda Sanitaria-Universitaria Integrata di Udine
Conditions:
Cardiac Output, Low
Liver Transplant; Complications
Eligibility:
All Genders
18-99 years
Brief Summary
The Swan-Ganz catheter is the gold standard to measure cardiac output during liver transplantation surgery. This is an invasive hemodynamic monitoring system. The VenArt Cardiac Output (Mespere LifeS...
Eligibility Criteria
Inclusion
- liver transplantation patients
Exclusion
- age \< 18 years old
- combined liver-kidney transplant
- liver transplant for acute insufficiency
- no consent of the patient
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2022
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04825015
Start Date
April 1 2021
End Date
December 15 2022
Last Update
August 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anesthesiology and Intensive Care Clinic - Department of Medicine - ASUIUD
Udine, Italy, 33100